Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026
Market Cap 1 91.84 79.88
Change - -13.02%
Enterprise Value (EV) 1 61.1 64.14
Change - 4.98%
P/E 21.2x 19.1x
PBR 1.04x 0.86x
PEG -1.1x -5.48x
Capitalization / Revenue 1.12x 0.84x
EV / Revenue 0.74x 0.68x
EV / EBITDA 7.34x 6.31x
EV / EBIT 16x 12.6x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 1.896 1.83
Distribution rate - -
Net sales 1 82.35 94.91
EBITDA 1 8.319 10.16
EBIT 1 3.821 5.079
Net income 1 3.947 4.179
Net Debt 1 -30.75 -15.75
Reference price 2 40.24 35.00
Nbr of stocks (in thousands) 2,282 2,282
Announcement Date 8/26/25 8/22/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 848K
-237.22x15.77x-282.62x-.--% 46.87B
23.8x2.17x12.27x0.88% 26.9B
15.28x1.22x6.95x5.73% 6.64B
1081.43x - - - 5.96B
51.82x9.56x32.91x0.97% 3.39B
-25.85x - - - 2.59B
-58.28x - - -.--% 2.24B
14.85x1.5x5.88x5.12% 2.09B
30.07x1.58x11.81x1.5% 1.83B
Average 99.55x 5.30x -35.47x 2.03% 9.85B
Weighted average by Cap. -39.29x 9.62x -145.06x 0.87%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited